Skip to main content

CORRECTION article

Front. Vet. Sci., 13 May 2024
Sec. Veterinary Infectious Diseases
Volume 11 - 2024 | https://doi.org/10.3389/fvets.2024.1423681

Corrigendum: Clinical validation of circulating immune complexes for use as a diagnostic marker of canine leishmaniosis

This article is a correction to:

  1. Clinical validation of circulating immune complexes for use as a diagnostic marker of canine leishmaniosis

    1. Read original article
\r\nJuliana SarquisJuliana Sarquis1Nuria ParodyNuria Parody2Ana MontoyaAna Montoya1Cristina Cacheiro-LlagunoCristina Cacheiro-Llaguno2Juan Pedro BarreraJuan Pedro Barrera1Rocío ChecaRocío Checa1María Angeles DazaMaría Angeles Daza3Jernimo CarnsJerónimo Carnés2Guadalupe Mir Guadalupe Miró1*
  • 1Department of Animal Health, Faculty of Veterinary, Universidad Complutense de Madrid, Madrid, Spain
  • 2R&D Unit Allergy and Immunology, LETI Pharma S.L.U., Madrid, Spain
  • 3Faculty of Veterinary, Small Animal Emergency and ICU Service, Veterinary Teaching Hospital, Universidad Complutense de Madrid, Madrid, Spain

A corrigendum on
Clinical validation of circulating immune complexes for use as a diagnostic marker of canine leishmaniosis

by Sarquis, J., Parody, N., Montoya, A., Cacheiro-Llaguno, C., Barrera, J. P., Checa, R., Daza, M. A., Carnés, J., and Miró, G. (2024). Front. Vet. Sci. 11:1368929. doi: 10.3389/fvets.2024.1368929

In the published article, there was an error. The symbol > is inverted.

A correction has been made to 3.3 CIC and laboratory findings, paragraph 7. This sentence previously stated:

“Dogs with borderline proteinuria (UPC = 0.2–0.5) had higher CIC levels than dogs without proteinuria (UPC > 0.5) (p = 0.035, r = 0.172).”

The corrected sentence appears below:

“Dogs with borderline proteinuria (UPC = 0.2–0.5) had higher CIC levels than dogs without proteinuria (UPC < 0.5) (p = 0.035, r = 0.172)”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Leishmania infantum, immune complexes deposition, canine leishmaniosis, biomarker, PEG-ELISA

Citation: Sarquis J, Parody N, Montoya A, Cacheiro-Llaguno C, Barrera JP, Checa R, Daza MA, Carnés J and Miró G (2024) Corrigendum: Clinical validation of circulating immune complexes for use as a diagnostic marker of canine leishmaniosis. Front. Vet. Sci. 11:1423681. doi: 10.3389/fvets.2024.1423681

Received: 26 April 2024; Accepted: 03 May 2024;
Published: 13 May 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Sarquis, Parody, Montoya, Cacheiro-Llaguno, Barrera, Checa, Daza, Carnés and Miró. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Guadalupe Miró, gmiro@ucm.es

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.